- Business
- Kuraray Co., Ltd. manufactures and sells specialty chemicals, functional resins, synthetic fibers, and related materials worldwide. The company produces polyvinyl alcohol (PVA) resins and films including optical-use poval film; polyvinyl butyral (PVB) resins and films such as Trosifol and SentryGlas interlayers for laminated safety glass; ethylene vinyl alcohol (EVOH) resins under the EVAL brand; methacrylic resins; isoprene chemicals; elastomers including GENESTAR polyamide resin and thermoplastic elastomers; medical and dental products through Kuraray Noritake Dental; PVA fibers under KURALON; man-made leather; nonwoven fabrics; hook-and-loop fasteners; polyester fibers; activated carbon including industrial recycled carbon; and high-performance membranes and systems for water treatment. Kuraray operates in Japan, the U.S., China, Europe, and other Asian regions from its headquarters in Tokyo, Japan, where it was founded on June 24, 1926. The company pursues business portfolio sophistication under its PASSION 2026 medium-term plan by expanding capacity in EVAL plants in the U.S., Europe, and a new facility in Singapore; growing dental materials and activated carbon businesses via acquisitions; increasing production of optical-use poval film and SentryGlas in Kurashiki; establishing a new cell culture laboratory for life innovation; developing sustainable raw materials and biomass-derived battery materials; optimizing methacrylates and restructuring nonwovens; improving isoprene and fibers profitability; and divesting artificial marble, biocarrier, ballast water management, golf courses, bone-graft substitutes, and diatomite businesses. In 2024, Kuraray cancels 30 million treasury shares, completes a share buyback of 414,900 shares worth 866 million yen, and establishes new shareholder return policies from fiscal 2025 targeting a total return ratio of 50% or more with maintained dividend increases and continuous buybacks.